Skinvisible, Inc. (SKVI)

Skinvisible Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.02	0.02	0.28	0.66	0.28	0.04
Revenue Growth (YoY)	-91.08%	-92.84%	-57.90%	140.76%	538.36%	-37.75%
Cost of Revenue	0.02	0.02	0	0	-122,923	0.02
Gross Profit	0	0	0.27	0.66	122,923	0.03
Selling, General & Admin	0.49	0.49	0.49	0.45	0.5	0.53
Other Operating Expenses	18,771	18,771	0.02	0.02	0.03	0.04
Operating Expenses	0.5	0.49	0.51	0.47	0.53	0.57
Operating Income	-0.49	-0.49	-0.24	0.19	-0.25	-0.54
Interest Income	0.34	0	1.16	1.21	1.19	1
Interest Expense	0.67	1.89	1.16	1.21	1.19	1
Other Expense / Income	0	0	0.99	1.26	1.19	1.16
Pretax Income	-1.16	-2.38	-1.22	-1.07	-1.45	-1.7
Income Tax	0.34	-0	0.99	1.21	1.19	1.02
Net Income	-1.16	-2.38	-2.21	-2.29	-2.64	-2.72
Shares Outstanding (Basic)	5	5	5	5	4	3
Shares Outstanding (Diluted)	5	5	5	5	4	3
Shares Change	-	-	-	1.06%	49.30%	-90.00%
EPS (Basic)	-0.26	-0.52	-0.49	-0.50	-0.59	-0.90
EPS (Diluted)	-0.26	-0.52	-0.49	-0.50	-0.59	-0.90
Free Cash Flow	-0.04	-0.09	0.04	0.35	0.03	-0.15
Free Cash Flow Per Share	-0.01	-0.02	0.01	0.08	0.01	-0.05
Gross Margin	5.89%	6.14%	98.28%	99.50%	44609181.28%	59.34%
Operating Margin	-2428.26%	-2451.90%	-85.37%	28.35%	-92.06%	-1250.47%
Profit Margin	-5788.78%	-11912.20%	-791.76%	-344.54%	-958.63%	-6306.55%
Free Cash Flow Margin	-186.04%	-432.44%	15.27%	53.32%	10.52%	-357.52%
EBITDA	-0.47	-0.47	-0.22	0.21	-0.22	-0.48
EBITDA Margin	-2334.11%	-2358.05%	-78.66%	31.05%	-80.43%	-1123.02%
Depreciation & Amortization	0.02	0.02	0.02	0.02	0.03	0.04
EBIT	-0.49	-0.49	-0.24	0.19	-0.25	-0.52
EBIT Margin	-2428.22%	-2451.91%	-85.37%	28.35%	-92.06%	-1214.79%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.